FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management

Back



1980N-0208
C 35
Volume 149

Comment

Advisory Committee on Immunization Practices. Use of anthrax vaccine in the United States. MMWR-Morbidity & Mortality Weekly Report 2000; 49 (RR-15): 1-20, http://www.cdc.gov/mmwr/PDF/rr/rr4915.pdf, part 2, part 3

Advisory Committee on Immunization Practices. General recommendations on immunization. MMWR-Morbidity & Mortality Weekly Report 2002; 51 (RR-2): 1-35. www.cdc.gov/mmwr/PDF/rr/rr5102.pdf, part 2

Brachman, P et al. Field Evaluation of a Human Anthrax Vaccine. American Journal of Public Health, volume 52, No. 4, April, 1962, pages 632-45. Published Material

Advisory Committee on Immunization Practices. Recommended childhood and adolescent immunization schedule - United States, 2005. MMWR-Morbidity & Mortality Weekly Report 2005: 53 (51); Ql-Q3, January 7, 2005, http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5351-Immunizationa1.htm

Atkinson WL, Pickering LK, Watson JC, Peter G. General immunization practices, In: Plotkin SA, Orenstein WA, ed. Vaccines, 4th ed, Philadelphia: Elsevier, 2003: 91-122. Published Material

Centers for Disease Control and Prevention. Limited supply of pneumococcal conjugate vaccine: Suspension of recommendation for fourth dose. MMWR-Morbidity & Motiahy Weekly Report 2004: 53 (05) 108-109; http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5305a6.htm

Centers for Disease Control & Prevention. Interim influenza vaccination recommendations, 2004-05 influenza season. MMWR-Morbidity & Mortality Weekly Report 2004; 53: 923-5. http://www.cdc.gov/mmwr/PDF/wk/mm5339.pdf

Centers for Disease Control & Prevention, 2005, http://www.cdc.gov/nip/recs/child-schedule.htm#catchup

Food and Drug Administration, Final Rule, 61 Federal Register 40153 (August 1, 1996).

General Accounting Office: GAO-02-987, "Childhood Vaccines: Ensuring an Adequate Supply Poses Continuing Challenges." September 2002. http://www.gao.gov/new.items/d02987.pdf

Hadler SC, de Monzon MA, Lugo DR, Perez M. Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians. Vaccine 1989; 7: 106-10. Published Material

Jilg W, Schmidt M, Deinhardt F. Immune responses to late booster doses of hepatitis B vaccine. Journal of Medical Virology 1985; 17: 249-54. Published Material

Marsano LS, West DJ, Chan I, Hesley TM, Cox J, Hackworth V, Greenberg RN. A two-dose hepatitis B vaccine regimen: Proof of priming and memory responses in young adults. Vaccine 1998; 16: 624-9. Published Material

McBean AM, Thorns ML, Albrecht P, et al. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. American Journal of Epidemiology 1988; 128: 615-28. Published Material

Pickering LK, ed. 2003 Red Book: Report of the Committee on Infectious Diseases, 26th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2003: 33. Published Material

Pittman PR, Hack D, Mangiafico J, Gibbs P, McKee KT Jr., Eitzen EM, Friedlander AM, Sjogren MH. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid. Vaccine 2002; 20 (May 15): 2107-15. Published Material

Pittman PR, Kim-Ahn G, Pifat DY, Coonan K, Gibbs P, Little Si Pace-Templeton JG, Myers R, Parker GW, Friedlander AM. Anthrax vaccine: Safety and iinmunogenicity of a dose-reduction, route comparison study in humans. Vaccine 2002; 20 (Jan 31): 1412-20. http://www.vaccines.mil/documents/library/Immunogenicity.pdf Published Material

Pittman PR, Mangiafico JA, Rossi CA, Cannon TL, Gibbs PH, Parker GW, Friedlander AM. Anthrax vaccine: Increasing intervals between the first two doses enhances antibody response in humans. Vaccine 2000; 18: 213-216. www.vaccines.mil/documents/library/Antibody_resp.pdf Published Material

Salk J. One-dose immunization against paralytic poliomyelitis using a noninfectious vaccine. Review of Infectious Diseases 1984; 6 (suppl2): S444-50. Published Material

Wistrom J, Ahlm C, Lundberg S, Settergren B, Tamvik A. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. Vaccine 1999; 17: 2162-5. Published Material


Top | Back

Page last updated July 27, 2005 RSChorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management